Department of Cardiovascular Sciences, Glenfield Hospital, Leicester, UK.
National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
Cardiovasc Res. 2023 Mar 31;119(2):599-610. doi: 10.1093/cvr/cvac092.
The non-coding locus at 6p24 located in Intron 3 of PHACTR1 has consistently been implicated as a risk allele in myocardial infarction and multiple other vascular diseases. Recent murine studies have identified a role for Phactr1 in the development of atherosclerosis. However, the role of PHACTR1 in vascular tone and in vivo vascular remodelling has yet to be established. The aim of this study was to investigate the role of PHACTR1 in vascular function.
Prospectively recruited coronary artery disease (CAD) patients undergoing bypass surgery and retrospectively recruited spontaneous coronary artery dissection (SCAD) patients and matched healthy volunteers were genotyped at the PHACTR1 rs9349379 locus. We observed a significant association between the PHACTR1 loci and changes in distensibility in both the ascending aorta (AA = 0.0053 ± 0.0004, AG = 0.0041 ± 0.003, GG = 0.0034 ± 0.0009, P < 0.05, n = 58, 54, and 7, respectively) and carotid artery (AA = 12.83 ± 0.51, AG = 11.14 ± 0.38, GG = 11.69 ± 0.66, P < 0.05, n = 70, 65, and 18, respectively). This association was not observed in the descending aorta or in SCAD patients. In contrast, the PHACTR1 locus was not associated with changes in endothelial cell function with no association between the rs9349379 locus and in vivo or ex vivo vascular function observed in CAD patients. This finding was confirmed in our murine model where the loss of Phactr1 on the pro-atherosclerosis ApoE-/- background did not alter ex vivo vascular function.
In conclusion, we have shown a role for PHACTR1 in arterial compliance across multiple vascular beds. Our study suggests that PHACTR1 has a key structural role within the vasculature.
位于 6p24 非编码基因座的 PHACTR1 内含子 3 中的风险等位基因已被一致确定为心肌梗死和多种其他血管疾病的风险等位基因。最近的鼠类研究已经确定了 Phactr1 在动脉粥样硬化发展中的作用。然而,PHACTR1 在血管张力和体内血管重塑中的作用尚未确定。本研究旨在探讨 PHACTR1 在血管功能中的作用。
前瞻性招募接受旁路手术的冠心病(CAD)患者,以及回顾性招募自发性冠状动脉夹层(SCAD)患者和匹配的健康志愿者,在 PHACTR1 rs9349379 基因座进行基因分型。我们观察到 PHACTR1 基因座与升主动脉(AA = 0.0053 ± 0.0004,AG = 0.0041 ± 0.003,GG = 0.0034 ± 0.0009,P < 0.05,n = 58、54 和 7)和颈动脉(AA = 12.83 ± 0.51,AG = 11.14 ± 0.38,GG = 11.69 ± 0.66,P < 0.05,n = 70、65 和 18)的顺应性变化之间存在显著关联。这种关联在降主动脉或 SCAD 患者中没有观察到。相比之下,在 CAD 患者中,PHACTR1 基因座与内皮细胞功能的变化没有关联,也没有观察到 rs9349379 基因座与体内或体外血管功能之间的关联。在我们的鼠类模型中,该发现得到了证实,即在动脉粥样硬化 ApoE-/- 背景下 Phactr1 的缺失并没有改变体外血管功能。
总之,我们已经证明了 PHACTR1 在多个血管床中的动脉顺应性中的作用。我们的研究表明,PHACTR1 在血管系统中具有关键的结构作用。